New Biopsy Shows Promise For Pancreatic Cancer Patients
Trovagene is developing a liquid biopsy for pancreatic cancer patients, to allow doctors to test for cancer and track treatment response.
Trovagene is developing a liquid biopsy for pancreatic cancer patients, to allow doctors to test for cancer and track treatment response.
A woman’s treatment for non-operable pancreatic cancer at Memorial Sloan Kettering includes FOLFIRINOX and stereotactic body radiation therapy.
New research finds that reducing antioxidants can help kill pancreatic cancer cells, suggesting a new direction for treatment.
Dr. Bert Vogelstein and his team at Johns Hopkins are working with a blood test called a liquid biopsy, which tests cells for mutations related to cancer.
Vitamin C has been found to kill cancer cells that carry the KRAS mutation. This mutation is common in pancreatic and colorectal cancers.